Hosted on MSN10m
FDA Clears Spravato For Monotherapy Depression Treatments
The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...
pharmaphorum42m
HPV self-collection: A step closer to eliminating cervical cancer
Cervical cancer is often highly treatable, with a five-year relative survival rate of 91% for localised, early-stage disease.
pharmaphorum49m
J&J's Spravato gets another lift with new FDA approval
The accelerating sales growth of Johnson & Johnson's Spravato could go up yet another gear after the FDA approved a third ...